Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 5701-5710 Newer>

The Motley Fool February 9, 2005 Rick Aristotle Munarriz	Anchored to Steiner Two more key renewals keep the floating spa specialist's prospects buoyant. The company has beaten analyst estimates for 10 straight quarters. It goes for 11 later this month.
The Motley Fool February 9, 2005 Rick Aristotle Munarriz	Krispy Kreme's Crash Diet As long as the company is able to make do with 25% less staff in some key operating areas, the slim-down will at least appease the creditors in the short term -- and perhaps the investors in the longer term.
InternetNews February 8, 2005 Colin C. Haley	Cisco Touts IP Telephony, Home Networking Cisco's advanced technology products performed well last quarter, but revenue concerns linger.
The Motley Fool February 8, 2005 Rich Smith	Buy When Wall Street Won't Three ways to profits when there's value inside: Buy what you know, seek out hidden value and profit from panic.
The Motley Fool February 8, 2005 Kelvin Taylor	Price Targets Mean Nothing When an analyst lowers his "price target," should you care? Other than causing wild swings in the market, they change nothing about the fundamentals of the company and don't reflect the true value of the stock.
The Motley Fool February 8, 2005 Stephen D. Simpson	Rent-A-Center Needs Change The rent-to-own furniture vendor must take real action to turn the business around and make this stock worth buying.
The Motley Fool February 8, 2005 Stephen D. Simpson	Has Arch Found Fools' Coal? Nation's No. 2 coal miner has a great 2004 but lowers expectations for 2005.
The Motley Fool February 8, 2005 Charly Travers	Good Prognosis for Biogen IDEC Blockbuster products help the biotech firm continue its stellar performance.
The Motley Fool February 8, 2005 W.D. Crotty	Is Asbestos Hazardous to This Stock? The Department of Justice issues an indictment against mining company W.R. Grace and seven executives in response to allegations that the company knowingly exposed townspeople and miners to airborne asbestos particles in Libby, Montana. Investors, take note.
The Motley Fool February 8, 2005 Charly Travers	Investing in a Cure Drugs in the pipeline offer potential breakthroughs for Alzheimer's disease. Instead of investing in small biotechs that have a lot riding on a single Alzheimer's program, the best way to invest in the field is through a diversified company
<Older 5701-5710 Newer> Return to current articles.